Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera

In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera Prevention of Lyme disease by the recombinant OspA-based vaccine reportedly works by preventing transmission of spirochetes from ticks to humans. We report on an in vitro microculture assay, which can be used to provide an indicator of the need for booster doses of vaccine. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical and Vaccine Immunology American Society For Microbiology

In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera

In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera

Clinical and Vaccine Immunology , Volume 9 (4): 919 – Jul 1, 2002

Abstract

Prevention of Lyme disease by the recombinant OspA-based vaccine reportedly works by preventing transmission of spirochetes from ticks to humans. We report on an in vitro microculture assay, which can be used to provide an indicator of the need for booster doses of vaccine.

Loading next page...
 
/lp/american-society-for-microbiology/in-vitro-assessment-of-antiborrelial-activity-of-ospa-vaccine-sera-vGEjK7DXSq

References (15)

Publisher
American Society For Microbiology
Copyright
Copyright © 2002 by the American Society For Microbiology.
ISSN
1556-6811
eISSN
1556-6811
DOI
10.1128/CDLI.9.4.919-920.2002
Publisher site
See Article on Publisher Site

Abstract

Prevention of Lyme disease by the recombinant OspA-based vaccine reportedly works by preventing transmission of spirochetes from ticks to humans. We report on an in vitro microculture assay, which can be used to provide an indicator of the need for booster doses of vaccine.

Journal

Clinical and Vaccine ImmunologyAmerican Society For Microbiology

Published: Jul 1, 2002

There are no references for this article.